fatnews.com

Discussion Forums
NEW!

Discussion Forums

Recent Forum Topics
NEW!

Recent Forum Topics
We welcome your comments, experience, expertise and insight on various topics about weight loss in these discussion forums.

STORE

The Store

SEARCH THIS SITE


Advanced Search

SEARCH THE WEB

Google

CONTACT US

  • Contact Us
  • Submit your suggestions to improve this site
  • Submit an article you would like reviewed
  • Suggest a drug, nutrient or diet you would like reviewed
  • TABLES

    BMI Table for adults
    BMI Table defining childhood obesity
    Glycemic Index Tables

    MEMBERS

    Login
    Register

    MAILING LIST

    CATEGORIES

    (Tip: To find articles about a particular subject, either search for a particular word, click "Category View" above, or select the category you are interested in from the list below.)
    5-HTP (5-Hydroxytryptophan)
    Abilify (aripiprazole)
    Acarbose (Precose)
    Accountability
    ACE Inhibitor
    Acetyl-L-Carnitine
    Acomplia (rimonabant)
    Actonel (risedronate)
    Actos (pioglitazone)
    Adiponectin
    Aging
    AIDS
    Air Conditioning
    Alcohol
    Alcoholism
    Alii (orlistat) - (also see Xenical)
    All-you-can-eat
    Allergies, Food and Brain
    Almonds
    Alpha Lipoic Acid
    Aluminum
    Alzhemier's Disease
    Amantadine (Symmetrel)
    Ambien (zolpidem)
    Amino Acids
    Amitriptyline (See Elavil)
    Amphetamines
    Amylase inhibitors (See Starch Blockers)
    Anafranil (clomipramine)
    Angina (chest pain)
    Animal-based diet
    Antibiotics
    Antidepressants
    Antihistamines
    Antipsychotic drugs
    Anxiety
    Arginine
    Arthritis
    Articles by others
    Artificial sweetners (general)
    Aspartic Acid
    Aspirin
    Asthma
    Attention Deficit Hyperactive Disorder -- ADHD
    Autism
    Avandia (rosiglitazone)
    Axokine
    Bariatric Surgery (See Weight Loss Surgery)
    Behavioral Therapy, Cognitive
    Belviq (lorcaserin hydrochloride)
    Benefits of weight loss
    Benzodiazepines
    Beta Blockers
    Binge Eating
    Bioidentical hormones
    Birth Control Pills
    Blacks
    Blood Donation
    Blood Pressure
    Blood Pressure Drugs
    Blood Pressure Drugs INCREASED Death in Older women
    Blood sugar
    BMI not perfect
    BMI Table
    BMI, Healthiest (Healthiest BMI)
    Body Composition
    Bone Fractures
    Bone mass
    Book - Blue Zones
    Book - Cholesterol Myths (by Uffe Ravnskov, MD, PhD)
    Book - Deadly Medicines and Organised Crime (by Prof. Peter Gøtzsche, MD)
    Book - Deadly Psychiatry and Organised Denial (by Prof. Peter Gøtzsche, MD)
    Book - Good Calories, Bad Calories (by Gary Taubes)
    Book - Malignant Medical Myths
    Book - Our Daily Meds
    Book - The Black Swan
    Book - Why We Get Fat (by Gary Taubes)
    Brain Allergies (See Allergies, Food and Brain)
    Breakfast
    Breast-feeding
    Broda Barnes, MD, PhD (thyroid expert)
    Bromocriptine (Ergoset)
    Bulimia
    Bupropion (See Wellbutrin)
    Byetta (exenatide)
    C-reactive protein
    Caffeine
    Calcium
    Calcium Channel Blockers
    Calorie content of food
    Calorie Density of Food
    Calorie Intake
    Calorie intake, Underreporting
    Calorie Restriction
    Cancer
    Cancer screening (Does it do any good?)
    Cancer treatments
    Cancer, Bladder
    Cancer, Bowel
    Cancer, Brain
    Cancer, Breast
    Cancer, Cervical
    Cancer, Colorectal
    Cancer, Endometrial
    Cancer, Gallbadder
    Cancer, Kidney
    Cancer, Leukemia
    Cancer, Liver
    Cancer, Lung
    Cancer, Multiple Myeloma
    Cancer, Non-Hodgkin Lymphoma
    Cancer, Oesophageal
    Cancer, Oesophageal (adenocarcinoma)
    Cancer, others
    Cancer, Ovarian
    Cancer, Pancreatic
    Cancer, Prostate
    Cancer, Stomach (gastric cardia)
    Cannabis (marijuana)
    Caralluma fimbriata
    Carbohydrates
    Carnitine, L- (L-carnitine)
    Carpal tunnel syndrome
    Celexa (citalorpam)
    Cell Phones
    Cereal
    Chelation Therapy, EDTA
    Chemtrails
    Chewing
    Childhood Illnesses
    Childhood neglect and abuse
    Childhood Obesity
    Chitosan
    Chocolate (cocoa)
    Cholesterol
    Cholesterol drugs
    Cholesterol Hypothesis Skeptics
    Cholesterol Myths
    Cholesterol, HDL
    Chromium
    Chronic Fatigue
    Citrus aurantium
    CLA (Conjugated Linoleic Acid)
    Clozaril (clozapine)
    Cobalt
    Cochrane Collaboration
    Codonopsis Eupolyphaga
    Coffee
    Coffee, Decaffeinated
    Cognitive function
    Commercial Weight Loss Programs
    Computer Use
    Conflicts of Interest
    Congestive Heart Failure
    Constipation
    Contrave (Wellbutrin (bupropion) plus naltrexone)
    Copper
    CoQ10 (Coenzyme Q10, ubiquinol, ubiquinone)
    Cortisol (stress hormone)
    Cost of food
    Costs associated with obesity
    Cravings
    Cymbalta (duloxetine)
    Daniel Amen, MD
    Death, Risk of
    Deaths from obesity
    Definitions
    Dental Amalgams (mercury fillings)
    Depo-Provera (depot-medroxyprogesterone acetate)
    Depression
    Desire to Lose Weight
    DHEA
    Diabetes
    Diabetes drugs
    Diagnosed Overweight by a Doctor
    Dialysis
    Diet drug use
    Diet Pills (General Info)
    Diet soda
    Dietary Counseling
    Diethylpropion (Tenuate)
    Dieting (General)
    Dieting, Intermittent
    Dinitrophenol
    Disability
    Discrimination against obesity
    Diuretics
    Diverticulitis
    Doctor - Abram Hoffer, MD, PhD
    Doctor - Boyd Haley, PhD
    Doctor - Dr. Kailash Chand
    Doctor - H. Gilbert Welch, MD (author of Overdiagnosed and Less Medicine, More Health)
    Doctor - Irving Kirsch, PhD
    Doctor - Jason Fung, MD
    Doctor - Joel Kauffman, PhD (author of Malignant Medical Myths)
    Doctor - John Abramson, MD (author of Overdosed America)
    Doctor - Jonathan Wright, MD (pioneer in natural medicine)
    Doctor - Kimber Stanhope, PhD
    Doctor - Malcolm Kendrick, MD author of "The Great Cholesterol Con"
    Doctor - Marcia Angell, MD
    Doctor - Mary Enig, PhD
    Doctor - Michel de Lorgeril, MD
    Doctor - Peter Gøtzsche, MD
    Doctor - Robert Lustig, MD
    Doctor - Suzanne Humphries, MD
    Doctor - Uffe Ravnskov, MD PhD
    Doctor - William Wilson, MD
    Doctor trends
    Don't fall for this
    Dopamine agonists
    Drug company lies
    Drug Company Money
    Drug Company Salesman
    Drug Company Tactics
    Drug-induced Side Effects
    Dry Skin
    Duodenal Switch (weight loss surgery)
    Eating time of day
    Economic Issues and Obesity
    Education
    Eggs
    Elavil (amitriptyline)
    Elderly
    Elderly, risk of obesity
    Empatic (Zonegran plus Wellbutrin)
    Environmental chemicals
    Ephedrine/Ephedra
    Epigenetics
    Erectile Dysfunction
    Escitalopram (Lexapro)
    Estrogen replacement therapy
    Evening Primrose Oil
    Every Other Day Modified Fast
    Excalia
    Exercise
    Exhaustion
    Fast Food
    Fasting, Intermittent
    Fat Cells
    Fat Intake (Dietary Fat)
    Fat loss
    Fat Oxidation
    Fat Replacers
    Fat, Body (Body Fat)
    Fat, Dietary
    FDA (U.S. Food and Drug Administration)
    Fen-Phen
    Fertility (see Pregnancy)
    Fiber (Dietary Fiber)
    Fiber supplements
    Fidgeting
    Fish
    Fish Oil (omega-3 fatty acids)
    Flaxseed
    Food Allergies (See Allergies, Food and Brain)
    Food Cues
    Food Diary
    Food Intake statistics
    Food preferences associated with obesity
    Food Pyramid
    Food Safety
    Food's effect on appetite
    Foods associated with higher and lower body weight
    Foods Associated with Weight Gain
    Forskolin (from the plant Coleus forskohlii)
    Fosamax (alendronate)
    Fructose
    Fruit
    Fucoxanthin
    GABA
    Gallbadder Disease
    Gallstones
    Garlic
    Gastro-esophageal reflux disease
    General Health Checks
    Genes and genetics
    Geodon (ziprasidone)
    Ghrelin
    Ginger
    Ginseng
    GLA (Gamma Linolenic Acid)
    GLA - Gamma Linolenic Acid
    Glucomannan (konjac root)
    Glucophage (metformin)
    Glutamine (amino acid)
    Glycemic Index
    Glycemic Index Tables
    Glycomacropeptide
    GMO foods (genetically modified organisms)
    Grains
    Grapefruit
    Green coffee bean extract
    Green Tea
    Group Therapy
    Growth Hormone
    Guar gum
    Gut Bacteria
    Gwen Olsen
    Habits associated with obesity
    Habits of being lean
    Hair Loss (caused by weight loss)
    Haldol (haloperidol)
    Hawaiian Diet
    HCG (human chorionic gonadotropin)
    Headaches
    Health Insurance
    Health Risks of obesity
    Heart Attack (myocardial infarction)
    Heart Disease
    Heart Disease, Coronary - Skeptics of the Cholesterol Hypothesis
    Heavy metal toxicity
    Herbal formula, Number Ten
    Herbal formula, PM-F2-OB
    Hibiscus tea
    High Carbohydrate Diet
    High-Fructose Corn Syrup
    High-Protein / Low-Carb Diets
    Histamine levels
    History
    Holiday Weight Gain
    Homocysteine
    Hoodia
    Hop extract, isomerized
    Hunger
    Hydralazine
    Hydrogenated vegetable oil (partially hydrogenated oil)
    Hydroxycitrate (HCA)
    Hypoglycemia
    Hypothyroidism, including Type 2 Hypothyroidism
    IGF-1 (insulin-like growth factor-1)
    Income level
    Infections
    Infertility
    Influenza (Flu)
    Injuries
    Insulin
    Insulin sensitivity
    Interview with Patients
    Interview with Stephen Gullo, PhD
    Interviews with Doctors
    Iodine
    Jenny Craig Weight Loss Program
    Joan Mathews Larson, PhD
    John Ioannidis
    Just for Fun
    Kidney Disease
    Kidney stones
    Kidney Stones
    Konjac root (See glucomannan)
    Krill Oil
    Lap Band Surgery
    Lead (heavy metal toxicity)
    Lean, things associated with being
    Legumes
    Leptin
    Lesbians
    Leucine (amino acid)
    Life Expectancy
    Lipolysis (release of fat from fat cells)
    Liposuction
    Lipozene (see glucomannan)
    Liquid Calories
    Liraglutide
    Longevity
    Lorcaserin (also see Belviq (lorcaserin hydrochloride))
    Low Calorie Diet
    Low Carbohydrate Diets
    Low Fat Diets
    Low Stomach Acid
    Lp(a)
    Ludiomil (maprotiline)
    Luvox (fluvoxamine)
    Magnesium
    Maitake mushroom
    Mammography
    Marijuana (see Cannabis)
    Mark Starr, MD
    Married or Single
    Meal Frequency
    Meal Replacement Shakes
    Measurments of obesity
    Meat, Red
    Mediterranean Diet
    Medium chain triglycerides (MCT's)
    Men, studies about
    Menopause
    Menstruation
    Mercury
    Mercury fillings (Dental amalgams)
    Meridia (sibutramine)
    Metabolic syndrome (also see Insulin Sensitivity)
    Metabolism
    Mifeprex (mifepristone)
    Milk and Dairy
    Mineral aspartates
    Mirapex (pramipexole)
    Mirtazapine (antidepressant Remeron)
    Moban (molindone)
    Monounsaturated fat (Olive Oil and Canola Oil)
    Mortality associated with obesity
    Motivational techniques for losing weight
    Movies
    MSG (monosodium glutamate)
    Multiple Myeloma (See Cancer, Multiple Myeloma)
    Myths, Medical Myths
    N-Acetyl-Cysteine (NAC)
    Naltrexone
    Nasal Blockage
    Nassim Taleb
    Natural Treatments
    Nestatin-1
    Neurontin (gabapentin)
    Niacin (vitamin B3)
    Nicotine
    Night Eating Syndrome
    Night workers/shift workers
    No Dinner Diet
    Nonalcoholic fatty liver disease
    Nortriptyline (See Pamelor)
    Nutrasweet (aspartame)
    Nuts (also see Almonds)
    Obesity Forecasts
    Obesity Guidelines, NIH
    Obesity statistics
    Obesity Statistics, US States
    Obesity, Causes of
    Obesity, Factors associated with
    Oleoyl-estrone
    Olestra
    Olive Oil
    Omega-3 Fatty Acids (fish oil)
    Omega-6 Fatty Acids
    Onions
    Oolong Tea
    Opinion
    Orthomolecular Medicine
    Over-treatment
    Paleo Diet
    Pamelor (nortriptyline)
    Parent's influence on obesity
    Parkinson's Disease
    Paroxetine (antidepressant Paxil)
    PCSK9 inhibitors (cholesterol-lowering drugs)
    Pedometer
    Periactin (cyproheptadine)
    Periodontal Gum Disease
    Personal stories about weigh loss
    Phen-Pro (Phentermine-Prozac or other SSRIs)
    Phendimetrazine (Bontril)
    Phentermine
    Phenylephrine
    Phosphodiesterase type-5 inhibitors, sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)
    Plastic's effect on body weight
    Plate Size
    Pokeweed extract
    Polar Weight Management Program
    Polio Vaccine (Salk Vaccine)
    Polycystic Ovarian Syndrome
    Polyunsaturated Fat
    Port, Sidney (UCLA statistician)
    Portion size, effect on calore intake
    Post-traumatic stress disorder
    Postnatal weight gain (immediately after birth)
    Postpartum depression
    Potassium
    Pramlintide (see Symlin)
    Predicted Weight Loss
    Pregnancy
    Pregnant women, effects on offspring
    Prejudice against obesity
    Prevalence of Obesity
    Prices for drugs
    Prolixin (fluphenazine)
    Prostate, Enlarged
    Protamine
    Protein (general)
    Protein Leverage Theory
    Protein Source
    Protein supplement
    Protein, High, Diet
    Protein, Low, Diet
    Protein, Soy
    Proton pump inhibitors
    Prozac (fluoxetine)
    PSA Test (Prostate Specific Antigen)
    Psychiatric Drugs
    Pu-erh Tea (Chinese Black Tea)
    Pursuing Weight Control
    Pyruvate
    Qsymia (phentermine and topiramate) (formerly Qnexa)
    Quality of Life
    Radiation (background ionizing radiation)
    Rate of Eating
    Raw food diet
    Red Yeast Rice
    Resistant Starch
    Resveratrol
    Rhodiola rosea (Golden root or Arctic root)
    Rice
    Richard Moore, MD, PhD
    Risperdal (risperidone)
    Ritalin (methylphenidate)
    Robert Skversky, MD
    Robert Whitaker (author & journalist)
    Rubidium
    Saccharin (artificial sweetner)
    Saturated Fat
    Sauna
    Scams
    Schizophrenia
    Seizures
    Self-help weight loss
    Self-reported height and weight
    Self-reported intake
    Serentil (mesoridazine)
    Serlect (sertindole)
    Seroquel (quetiapine)
    Serotonin Syndrome
    Serzone (nefazodone)
    Sex and Sexual Activity
    Sexual abuse
    Shift Workers
    Sick Days
    Simmondsin (jojoba plant seed extract)
    Skinny on Obesity video series
    Sleep
    Sleeping pills
    Smoking's effect on weight
    Snacks
    Snoring
    Social Influence
    Sodium Intake
    Soft drinks (Coke, Pepsi, etc.)
    South Beach Diet
    Splenda (sucralose)
    Spouses
    SSRI's
    Starch Blockers (Amylase inhibitors)
    Statin Nation (documentary)
    Statins
    Stearic Acid (in beef and chocolate)
    Stents (coronary artery stents)
    Strattera (atomoxetine)
    Strength Training
    Stress
    Stroke
    Sugar Addiction
    Sugar intake
    Suicide
    Sumatriptan
    Sun Bathing, Benefits of
    Surmontil (trimipramine)
    Symlin (pramlintide)
    Symlin (pramlintide)
    Sympathetic Nervous Activity (SNS)
    Taranabant
    Taste
    Taubes, Gary
    Taxes and Obesity
    Tea
    Television Watching
    Temperature, House
    Tenuate (See diethylpropion)
    Tesofensine
    Testosterone
    Thermogenesis
    Thermography
    Thiomersal (mercury-containing preservative)
    Thorazine (chlorpromazine)
    Thyroid Function
    Thyroid supplement
    Thyroid, Desiccated
    Timeline related to obesity discoveries
    Tofranil (imipramine)
    Tofu (soybean curd)
    Tonsils
    Too much medicine
    Topamax (topiramate)
    TOPS (Take Off Pounds Sensibly)
    Trans Fats
    Trazedone (antidepressant)
    Tricyclic antidepressants
    Triglyceride levels
    Tryptophan
    Underreporting weight
    Urinary incontinence
    Vaccines
    Vegetable-based Diet
    Vegetables
    Vegetables, Raw
    Vegetarians
    Venlafaxine (antidepressant Effexor)
    Ventricular arrhythmias
    Vertical Banded Gastroplasty
    Very-Low-Calorie Diets
    Vibration, Whole Body
    Vinegar
    Virus and Bacteria associated with obesity
    Virus, obesity (adenovirus-36)
    Visual Cues
    Vitamin C
    Vitamin D
    Vitamins
    Waist measurement
    Waist-to-Hip Ratio
    Wansink, Brian (studies done by)
    Water
    Weighing, Self
    Weight cycling (gaining and losing)
    Weight gain
    Weight Lifting
    Weight Loss Expectations
    Weight Loss Programs
    Weight Loss Strategies
    Weight Loss Success (what successful weight losers do)
    Weight Loss Supplements
    Weight Loss Supplements, Adulterated
    Weight loss surgery
    Weight Loss Surgery - Laparoscopic Sleeve Gastrectomy
    Weight Loss, Benefits of
    Weight loss, Rate of
    Weight loss, risks of
    Weight Maintenance
    Weight monitoring
    Weight Perception
    Weight Watchers
    Weight-gaining drugs
    Wellbutrin (bupropion)
    Wine, Red
    Women, studies about
    Work, Lost Days
    Xenical (orlistat)
    YouTube videos
    Zerona laser
    Zetia (ezetimibe)
    Zinc
    Zocor (simvastatin)
    Zoloft (sertraline)
    Zonegran (zonisamide)
    Zyprexa (olanzapine)

    ARCHIVES

    June, 2017
    May, 2017
    April, 2017
    March, 2017
    February, 2017
    January, 2017
    December, 2016
    November, 2016
    October, 2016
    September, 2016
    August, 2016
    July, 2016

    ARCHIVE SUMMARY

    View by Date
    View by Category

    RSS / XML


    RSS 1.0
    RSS 2.0
    RSS Atom

    WEATHER

    Weather around the country

    QUOTE OF THE DAY

    QUICKLINKS AND VIEW OPITONS

  • Articles with Recent Comments
  • Recent Forum Topics
  • Summary View
  • Headline View
  • Archive of Quotes
  • SUMMARY VIEW

    NEW! Page 1 of 2. Go to page  1 2 > 

    Wednesday, December 21, 2016

    PROTEIN SOURCE

    Replacing 3% of calories from red meat with plant protein reduces risk of death by 12% over 26-32 yr

    Replacing 3% of calories from red meat with plant protein was associated with a 12% lower risk of death over 26-32 years according to a recent analysis from researchers from Harvard University.

    This is the equivalent of replacing roughly 15-20 grams of protein from red meat with plant protein for people eating a diet containing 1800-2500 calories per day.

    A McDonald’s hamburger contains 12 grams of protein.

    A quarter-pound hamburger contains 24 grams of protein.

    A 9-ounce steak contains 70 grams of protein.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Dec 21, 2016 12:53 pm | [0] comments

    PROTEIN SOURCE

    Replacing 3% of calories from processed red meat with plant protein reduces risk of death by 18%

    Replacing 3% of calories from processed red meat like sausage, bacon, ham, corn beef, cold cuts, smoked meats, dried meat, beef jerky, canned meat and hot dogs with plant protein was associated with a 18% lower risk of death over 26-32 years according to a recent analysis from researchers from Harvard University.

    This is the equivalent of replacing roughly 15-20 grams of protein from processed red meat with plant protein for people eating a diet containing 1800-2500 calories per day.

    A hot dog contains 5 grams of protein.

    Three slices of bacon contains 9 grams of protein.

    Three ounces of sausage contains 10 grams of protein.

    Three ounces of corned beef contains 15 grams of protein.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Dec 21, 2016 12:21 pm | [0] comments

    PROTEIN SOURCE

    Replacing 3% of calories from eggs with plant protein reduces risk of death by 19% over 26-32 years

    Replacing 3% of calories from eggs with plant protein was associated with a 19% lower risk of death over 26-32 years according to a recent analysis from researchers from Harvard University.

    This is the equivalent of replacing roughly 15-20 grams of protein from red meat with plant protein for people eating a diet containing 1800-2500 calories per day.

    Two (2) eggs contain 12 grams of protein.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Dec 21, 2016 12:02 pm | [0] comments

    Wednesday, June 24, 2009

    ACOMPLIA

    John lost 60 lbs with Taranabant, but found Acomplia had no effect

    Here is an interesting post from "JohnTall". I am posting it here so that more people will see it.

    "Nearly two years ago I posted a note detailing my experience with Taranabant. In that post I fudged my actual weights for concern that Merck might be able to identify me and end my participation in the trial. Since then Merck has pulled the plug on Taranabant and I am no longer concerned about them knowing that I am posting.

    My actual experience was that I started at 244 pounds and I lost to 183 in 101/2 months (61 pounds lost). I then slowly regained 9 pounds to 192 and that was my weight when I left the study in December of 2007. I was in the study for 27 months." Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 24, 2009 11:12 am | [0] comments

    Thursday, October 23, 2008

    ACOMPLIA

    European drug agency recommends sales of Acomplia be stopped in Europe because of risks

    The “benefits of Acomplia no longer outweigh its risks and the marketing authorisation should be suspended across the European Union" according to a recommendation by the European Medicines Agency (EMEA) to French drugmaker Sanofi Aventis on October 23rd, 2008.

    The European Medicines Agency is based in London and regulates treatments in the 27 nations of the European Union.

    The EMEA has determined that Acomplia doubles the risk of psychiatric disorders such as anxiety, depression, panic attacks and "suicidal ideation".

    The drug has been taken by more than 700,000 people worldwide.

    Acomplia was linked to 5 deaths and 720 adverse drug reactions in Britain in the past two years according to a report in June 2008.

    The drug has never been approved for sale in the U.S., but has been available in the EU since June 2006.

    Because of this, it is likely that it will never be approved for sale in the U.S. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Oct 23, 2008 12:13 pm | [0] comments

    ACOMPLIA

    Sanofi-Aventis had long rejected concerns over the Acomplia’s psychiatric side effects

    "Sanofi-Aventis [the drug company that makes Acomplia] had long rejected concerns over [Acomplia's] psychiatric side- effects, but failed to win approval for it from the US Food & Drug Administration," according to the Financial Times.

    "Warnings to patients on the drug's use have been strengthened several times since its launch in Europe in 2006."

    "The company said it 'believes that Acomplia will remain an important therapeutic answer to a highly prevalent and increasing unmet medical need', and pledged to continue studies on its use for patients with diabetes and at risk of cardiovascular disease." Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Oct 23, 2008 12:04 pm | [0] comments

    ACOMPLIA

    European drug agency notes Acomplia less effective in practice than the studies suggested

    [The European Medicines Agency's (EMEA's) Committee for Medicinal Products for Human Use (CHMP)] noted, that the effectiveness of Acomplia in clinical practice is more limited than was expected on the basis of the clinical trials, because available data indicate that patients generally take Acomplia only for a short period," according to a press release from the European Medicines Agency which recommended sales of Acomplia be suspended in Europe.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Oct 23, 2008 9:52 am | [0] comments

    ACOMPLIA

    Acomplia has been sold in 18 European countries since June 2006

    "Acomplia has been authorised in the European Union since June 2006 and is marketed in 18 EU Member States" which include "Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Lithuania, Malta, the Netherlands, Slovakia, Spain, Sweden and the United Kingdom" according to a Question and Answer document from the European Medicines Agency. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Oct 23, 2008 9:44 am | [0] comments

    Wednesday, June 04, 2008

    ACOMPLIA

    Five deaths in the UK have been associated with Acomplia (rimonobant)

    Acomplia (rimonobant) has been cited in 5 deaths and 720 adverse drug reactions in the UK according to figures published on June 3rd, 2008 by the Medicines and Healthcare products Regulatory Agency (MHRA).

    One person on the drug committed suicide. Another person died from an infection, while three others died from heart attacks.

    The European Union approved Acomplia in 2006. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:59 am | [0] comments

    ACOMPLIA

    Depressive reactions may occur in up to 10% of patients treated with Acomplia (rimonabant)

    "Depressive reactions may occur in up to 10% of patients treated with [Acomplia] rimonabant," notes a report from the UK's Medicines and Healthcare products Regulatory Agency.

    "Rimonabant is [ should not be used by ] patients with ongoing major depression or those taking antidepressants."

    "mportant risks that were identified during clinical development were depressive disorders, anxiety, sleep disorders, and sensory neurological disturbances." Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:38 am | [0] comments

    ACOMPLIA

    Half of cases of depression associated with Acomplia (rimonabant) occur within first 2 weeks

    Acomplia (rimonabant) can cause depression in 10 percent of patients who take it. One-third of these cases occur within the first week, and nearly one-half within the first two weeks notes a report from the UK's Medicines and Healthcare products Regulatory Agency. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:32 am | [0] comments

    ACOMPLIA

    15 cases of paranoia associated with Acomplia (rimonabant)

    As of January 2008 there had been 15 reports of paranoia caused by Acomplia (rimonabant) according to a report from the UK's Medicines and Healthcare products Regulatory Agency. Some, but not all, cases were in association with depression. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:20 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) most common adverse effects

    The most common adverse reactions associated with Acomplia (rimonabant), notes a report from the UK's Medicines and Healthcare products Regulatory Agency, include:
    • Psychiatric disorders (depression, anxiety, nervousness, irritability, sleep disorders, parasomnias where a patient is aroused during sleep and caught between being awake and a sleep)

    • Nervous-system disorders (memory loss, dizziness, hypoesthesia (reduced sense of touch or sensation), paraesthesia (tingling, pricking, or numbness of a person's skin))

    • Gastrointestinal disorders (nausea, diarrhoea, vomiting)

    • General disorders (fatigue, asthenia (a feeling of weakness))

    • Skin and subcutaneous disorders (itching, sweating)
    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:16 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) sales total $122 million for 2007

    Sales for Acomplia (rimonabant) in 2007 totaled 79 million euros which is approximately $122 million. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 04, 2008 6:14 am | [0] comments

    Wednesday, April 02, 2008

    ACOMPLIA

    People lose 9.5 lbs in 1.5 years with 20 mg of Acomplia vs 1.1 lbs with placebo

    People given 20 mg of Acomplia per day along with dietary counseling lost an average of 9.5 pounds after 1.5 years compared to a weight loss of 1.1 pounds for those given a placebo according to a new study called the STRADIVARIUS study. The study involved 839 patients at 112 centers in North America, Europe, and Australia. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Apr 02, 2008 6:58 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : Psychiatric side effects reported by 43% of patients vs 28% with placebo

    "Significant psychiatric and gastrointestinal tract adverse effects were observed [ in people given 20 mg of Acomplia ( rimonabant ) ] but were usually mild or moderate in severity," noted the authors of the STRADIVARIUS study that involved 839 patients at 112 centers in North America, Europe, and Australia.

    A total of 43.4 percent of those given Acomplia ( rimonabant ) reported psychiatric side effects versus 28.4 percent of those given a placebo.

    "These adverse events consisted primarily of an increase in anxiety and depression," the authors noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Apr 02, 2008 6:50 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant): Major depression or suicidal thoughts : 4.7% of patients vs 3.8% with placebo

    Severe psychiatric adverse effects, defined as major depression, thoughts of suicide, or attempted or successful suicide occurred with 4.7 percent of patients given 20 mg of Acomplia ( rimonabant ) per day versus 3.8 percent of those given a placebo according to the STRADIVARIUS study that involved 839 patients at 112 centers in North America, Europe, and Australia.

    "A single patient in the placebo group attempted suicide, and a single patient in the rimonabant [ Acomplia ] group successfully completed suicide," the paper noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Apr 02, 2008 6:39 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant): Gastrointestinal side effects in 33.6% of patients vs 17.8% with placebo

    Gastrointestinal side effects were reported by 33.6 percent of patients given 20 mg of Acomplia ( rimnoabant ) per day versus 17.8 percent of those given a placebo according to the STRADIVARIUS study that involved 839 patients at 112 centers in North America, Europe, and Australia. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Apr 02, 2008 6:27 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant): Dropouts due to side effects : 17.5% of patients vs 7.5% with placebo

    A total of 17.5 percent of patients given 20 mg of Acomplia ( rimnoabant ) per day dropped out of the study due to side effects versus 7.5 percent of those given a placebo according to the STRADIVARIUS study that involved 839 patients at 112 centers in North America, Europe, and Australia. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Apr 02, 2008 6:22 am | [0] comments

    Friday, November 16, 2007

    ACOMPLIA

    Acomplia (rimonabant) causes an average weight loss of 10.3 pounds more than placebo

    Acomplia (rimonabant) causes an average weight loss of 10.3 pounds more than placebo according to an analysis by researchers from the University of Alberta in Edmonton, Alberta, Canada. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:39 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) side effects : Irritability, insomnia, stress, and nervousness

    Side effects that have been reported with Acomplia (rimonabant) according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark include:
    • irritability

    • insomnia

    • stress

    • nervousness

    • panic attacks

    • agitation

    • nightmare

    • abnormal dreams
    "Although the number of patients discontinuing therapy because of adverse events seemed to be small, high study attrition rates raise the possibility that some events were not documented," Astrup noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:35 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : Psychiatric side effects reported by 26% of patients

    Psychiatric side effects such as depression and anxiety have been reported with 26 percent of patients given Acomplia (rimonabant) compared to 14 percent of those given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark.

    This is despite the fact that "[all of] the included trials excluded patients with existing depression, or those with a history [of depression]," as Astrup noted.
    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:25 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : 9% of patients needed anti-anxiety medication

    Nine percent of patients given 20 mg of Acomplia (rimonabant) required anti-anxiety medication or sleep medication compared to 4 percent of those given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:23 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : 5% of patients needed antidepressant medication

    Five percent of patients given 20 mg of Acomplia (rimonabant) required anti-depressant medication compared to 3 percent of those given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark.

    This is despite the fact that "[all of] the included trials excluded patients with existing depression, or those with a history [of depression]," Astrup noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:22 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : 3% of patients dropped out of studies due to depression

    Three percent of patients given Acomplia (rimonabant) dropped out of studies due to depression compared to 1.4 percent given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark. This means that dropouts due to depression are 2.5 times as likely with Acomplia (rimonabant) than with placebo.

    This is despite the fact that "[all of] the included trials excluded patients with existing depression, or those with a history [of depression]," Astrup noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:21 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : 1% of patients dropped out of studies due to anxiety

    One percent of patients given Acomplia (rimonabant) dropped out of studies due to anxiety compared to 0.3 percent given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark. This means that dropouts due to depression are 3 times as likely with Acomplia (rimonabant) than with placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:15 am | [0] comments

    ACOMPLIA

    Acomplia (rimonabant) : 2 suicides in obesity studies so far

    There have been two suicides in patients given Acomplia (rimonabant) in obesity studies so far according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark. One patient was taking 20 mg, while the other patient was taking 5 mg.

    This is despite the fact that "[all of] the included trials excluded patients with existing depression, or those with a history [of depression]," Astrup noted. Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Nov 16, 2007 10:09 am | [2] comments

    Monday, November 12, 2007

    ACOMPLIA

    Weight loss with Acomplia: Lost 12 lbs while also on low-carb diet, but gained it all back

    Here is a story posted in one of the Discussion Forums about weight loss with Acomplia. Read the entire article | Email this article
    Posted by Larry Hobbs on Mon, Nov 12, 2007 7:06 am | [2] comments

    Monday, July 23, 2007

    ACOMPLIA / ZIMULTI

    One in 10 who take Acomplia may develop depression, 1 in 100 have suicidal thoughts

    Evidence from the United Kingdom suggests that Acomplia (rimonobant), also known as Zimulti, causes psychiatic side effects in roughly one of 10 people who take it and suicidal thoughts in approximately one out of 100. Read the entire article | Email this article
    Posted by Larry Hobbs on Mon, Jul 23, 2007 1:44 am | [0] comments

    Thursday, June 14, 2007

    ACOMPLIA

    FDA Advisory Committee recommends against approval of Acomplia (rimonabant)

    Yesterday, an FDA advisory committee recommended that the U.S. Food and Drug Administration (FDA) not approve Acomplia (rimonabant) because of concerns about an increased risk of suicide and psychiatric problems associated with the drug. The FDA will makes its final decision on July 26th, 2007. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 2:40 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) blocks cannabinoid receptor: What are the implications?

    Acomplia (rimonabant) reduces appetite by blocking a receptor called the cannabinoid-1 receptor. Stimulation of these and other receptors help to protect against anxiety, phobias, depression and posttraumatic stress disorders. Stimulation of these receptors may also protect against neurotoxicity and some forms of epilepsy. Therefore, drugs that block this receptor, such as Acomplia (rimonabant), should not be used carefully and monitored closely in patients with anxiety, depression, epilepsy and neurodegenerative disorders according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 2:21 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) increases need for antidepressants

    Acomplia (rimonabant) increased the need for antidepressant drugs according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Antidepressant were prescribed for 4.8 percent of patients on 20 mg of Acomplia versus 2.9 percent of patients on placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:41 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) increases need for anti-anxiety drugs and sleeping pills

    Acomplia (rimonabant) increased the need for anti-anxiety drugs and sleeping pills according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. These drugs were prescribed for 8.5 percent of patients taking 20 mg of Acomplia versus 4.1 percent of patients on placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:37 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) side effects: Insomnia

    Acomplia (rimonabant) increases the risk of insomnia according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Insomnia occurred in 5.4 percent of people given 20 mg per day compared to only 3.3 percent of people given a placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:31 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) side effects: Anxiety

    Acomplia (rimonabant) doubles the risk of anxiety according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Six (6) percent of those given 20 mg per day reported anxiety compared to only 2.5 percent of people given a placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:29 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) side effects: Irritability

    Acomplia (rimonabant) increases the risk of irritability which occurred in 1.9 percent of people given 20 mg per day versus 0.6 percent of people given a placebo according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:27 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) side effects: Psychiatric symptoms

    Acomplia (rimonabant) increases the risk of psychiatric symptoms according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Twenty-six (26) percent of those given 20 mg per day had psychiatric symptoms compared to 14 percent of people given a placebo. Psychiatric symptoms include things like depression, anxiety, insomnia, nervousness, panic attacks, etc. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:26 am | [0] comments

    ACOMPLIA

    Acomplia’s (rimonabant) side effects: Depression

    Acomplia (rimonabant) increases the risk of depression according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Nine (9) percent of those given 20 mg per day reported depression compared to 5 percent of people given a placebo. Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jun 14, 2007 1:24 am | [0] comments

    Wednesday, June 13, 2007

    ACOMPLIA

    Acomplia’s (rimonabant) side effects reported

    The most frequently reported side effects reported from patients taking Acomplia (rimonabant) in the 30 countries where the drug is already approved and being sold include nausea, diarrhea, vomiting, anxiety, depression, insomnia, dizziness, headache, unusual skin sensations, tremor, sleepiness, amnesia and difficulty with attention according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 13, 2007 3:41 am | [2] comments

    ACOMPLIA

    Acomplia’s (rimonabant) approved in 30 countries

    Acomplia (rimonabant), at a dose of 20 mg once-per-day, has been approved in 30 countries in Europe, South America and Asia according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jun 13, 2007 3:29 am | [0] comments
    NEW! Page 1 of 2. Go to page  1 2 > 

    © Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.

    Articles with Recent Comments from Readers
    (Click here to see a complete list)
  • Acomplia’s (rimonabant) side effects reported

  • Weight loss with Acomplia: Lost 12 lbs while also on low-carb diet, but gained it all back

  • Acomplia (rimonabant) : 2 suicides in obesity studies so far

  • Acomplia (rimonabant) approved for sale in Europe on June 21st, 2006

  • Acomplia (rimonabant) increases thermogenesis as well as initially reducing appetite

  • Acomplia (rimonabant) causes an average weight loss of 19 pounds for two years

  • Acomplia (rimonabant) side effects: nausea, dizziness, and upper respiratory tract infections

  • Acomplia (rimonabant): 5 mg per day causes average weight loss of 7.9 lbs, 20 mg 18.9 lbs

  • New diet drug for losing weight and stopping smoking

  • Replacing 3% of calories from red meat with plant protein reduces risk of death by 12% over 26-32 yr

  • Replacing 3% of calories from processed red meat with plant protein reduces risk of death by 18%

  • Replacing 3% of calories from eggs with plant protein reduces risk of death by 19% over 26-32 years

  • John lost 60 lbs with Taranabant, but found Acomplia had no effect

  • European drug agency recommends sales of Acomplia be stopped in Europe because of risks

  • Sanofi-Aventis had long rejected concerns over the Acomplia’s psychiatric side effects

  • European drug agency notes Acomplia less effective in practice than the studies suggested

  • Acomplia has been sold in 18 European countries since June 2006

  • Five deaths in the UK have been associated with Acomplia (rimonobant)

  • Depressive reactions may occur in up to 10% of patients treated with Acomplia (rimonabant)

  • Half of cases of depression associated with Acomplia (rimonabant) occur within first 2 weeks

  • 15 cases of paranoia associated with Acomplia (rimonabant)

  • Acomplia’s (rimonabant) most common adverse effects

  • Acomplia (rimonabant) sales total $122 million for 2007

  • People lose 9.5 lbs in 1.5 years with 20 mg of Acomplia vs 1.1 lbs with placebo

  • Acomplia (rimonabant) : Psychiatric side effects reported by 43% of patients vs 28% with placebo

  • Acomplia (rimonabant): Major depression or suicidal thoughts : 4.7% of patients vs 3.8% with placebo

  • Acomplia (rimonabant): Gastrointestinal side effects in 33.6% of patients vs 17.8% with placebo

  • Acomplia (rimonabant): Dropouts due to side effects : 17.5% of patients vs 7.5% with placebo

  • Acomplia (rimonabant) causes an average weight loss of 10.3 pounds more than placebo

  • Acomplia (rimonabant) side effects : Irritability, insomnia, stress, and nervousness

  •  
    Recent Forum Topics

    (Please share your comments & experience)
  • Welcome!
    07/03/2013 07:22 pm

  • Acomplia - what is your personal opinion?
    02/15/2013 02:42 pm

  • The different components of weight and how they vary over time
    07/04/2012 05:54 pm

  • How weight varies as we sleep
    07/04/2012 05:48 pm

  • Beer
    06/15/2012 12:42 am

  • Wellbutrin, Topamax and Phentermine
    05/16/2012 04:00 pm

  • Want to Take Phen-Pro
    03/13/2012 09:07 pm

  • I recently got a prescription for phentermine
    12/30/2011 12:20 pm

  • Topamax plus Wellbutrin = no appetite
    12/26/2011 04:59 pm

  • Thinking of doing Dr. Joan Mathews Larson’s Health Recovery Center
    12/06/2011 07:02 pm

  • Phentermine
    07/23/2011 09:11 am

  • Phentermine and Nicotine
    07/15/2011 12:02 am

  • In there any conflict taking ephedra with 5-HTP
    05/08/2011 03:55 pm

  • 7-keto lessens carb cravings?
    05/05/2011 04:45 pm

  • Does Requip (ropinirole) cause weight gain?
    04/20/2011 08:46 pm

  • The Acai Berry Hoax??
    01/31/2011 07:47 am

  • Phentermine and Heart Rate
    12/22/2010 09:30 pm

  • Long Time on Phentermine
    07/05/2010 07:43 am

  • Main Site Link and Howdy
    01/28/2010 02:08 pm

  • Modafinil and Adrafinil
    01/17/2010 07:30 am

  • How should i use EAS Betagen?
    12/13/2009 09:15 am

  • Is it suitable?
    12/12/2009 11:56 am

  • Ephedrine and caffeine - Still quite popular among bodybuilders cutting fat
    11/13/2009 05:19 pm

  • Phenobarbital and Elsinore Pill
    11/09/2009 08:24 pm

  • Methylephedrine and Pseudoephedrine
    11/09/2009 10:57 am

  • 262,000 Calories and Hopelessness
    11/04/2009 07:43 pm

  • Has anyone used DEX-C20? (new herbal diet pill made of Caralluma Fimbriata)
    10/19/2009 11:41 am

  • Correct dosage?
    09/08/2009 11:24 am

  • General Tips for Fast Weight Loss
    07/10/2009 09:26 am

  • Arginine is working
    06/24/2009 11:27 am

  •